Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial
Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dean Bornilla has been named Head of Commercial reporting to Dawn Von Rohr, President, Pace® Life […]
Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial Read More »